Pulmonary Arterial Hypertension (PAH) is a rare, progressive form of a serious heart-lung condition known as pulmonary hypertension. As advocates step forward, their firsthand experiences are reshaping education and support for those impacted. This evolving approach promises more accessible and effective resources for patients.